EPHA2 and glioblastoma: Further analysis on clinical treatment efficacy using TCGA_GBM database showed that GBM with PDGFRA and EPHA2 was insensitive to radiation or/and chemotherapy but GBM without PDGFRA and EPHA2 responded well to clinical treatment strategy.